Latest disclosed round
Series C
- Date
- 2024-08-01
- Amount
- USD 47m
- Sector
- Biotech & techbio; Healthtech & digital health
- Companies House
- 09018507
Later stage / growth
Healx
AI drug discovery (rare disease); AI drug discovery (rare disease) — borderline biotech/healthtech
CandidateSeries CCambridge
Evidence status
Review retained
- Identity
- Candidate
- Match
- High candidate
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
10 linked investors
Funding record
1 disclosed round
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2024-08-01 | Series C | $47M / £37M | R42 Group, Atomico, Balderton, Jonathan Milner, Global Brain, btov, Ayana Capital, o2h Ventures, VU Venture Partners |
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.